Aurora Cannabis has delivered $10 million worth of medical cannabis shipment to Israel.
The sale builds on the Company's growing presence in Israel, a key market as Aurora continues to strengthen its international medical business.
"It's an exciting time for the global cannabis industry, as we're seeing growing acceptance and thoughtful regulation of both medical and adult-use cannabis across Europe and in key markets like Israel," says Miguel Martin, Chief Executive Officer of Aurora. "With strong local relationships, as well as support from our patients and consumers, we look forward to continuing to expand our international business to complement our total cannabis portfolio."
For more information: